Treatment of bronchial asthma with tianeptine
- PMID: 15632955
- DOI: 10.1358/mf.2004.26.9.872567
Treatment of bronchial asthma with tianeptine
Abstract
Although circulating catecholamines and free serotonin in the plasma (f-5-HT) were found to be increased during asthma attacks, only f-5-HT levels correlated positively with bronchoconstriction and clinical severity. Tianeptine, a drug that enhances serotonin uptake by platelets and serotonergic axons at the central nervous system (CNS), provoked an abrupt disappearance of asthma attacks. This fact explains why tianeptine has proven to be a powerful therapeutic tool in controlling asthma. Its success has been demonstrated not only in two double-blind placebo, cross-over trials, but through an open study lasting more than seven years that included over 25,000 asthmatic patients. In the present article, we discuss the peripheral and central nervous system mechanisms that may explain the therapeutic success of tianeptine. These are summarized below. F-5-HT is taken up by pulmonary endocrine cells (PNEC) located at the parasympathetic terminals. A presynaptic element, these cells release serotonin and potentiate acetylcholine (ACh)-induced contraction of bronchial muscle. This effect is mediated by 5-HT(3) and 5-HT(4) postsynaptic receptors located at the bronchial muscle. According to the above, the increased f-5-HT plasma level, triggered by both platelet aggregation and nocturnal and/or diurnal hyperparasympathetic activity, potentiates ACh-induced bronchoconstriction. The fact that serotonin released by medullary serotonergic axons stimulates the medullary vagal cardiorespiratory neurons obliges us to think that serotonin-induced CNS mechanisms are also involved. Furthermore, the finding that drugs that interfere with serotonin uptake, by both platelets and 5-HT-terminals, worsen asthma symptoms and are able to provoke asthma attacks gives additional support to the above peripheral and CNS mechanisms.
Copyright 2004 Prous Science. All rights reserved.
Similar articles
-
Neuropharmacologic treatment of bronchial asthma with the antidepressant tianeptine: a double-blind, crossover placebo-controlled study.Clin Pharmacol Ther. 1998 Aug;64(2):223-32. doi: 10.1016/S0009-9236(98)90156-4. Clin Pharmacol Ther. 1998. PMID: 9728903 Clinical Trial.
-
The serotonin uptake-enhancing drug tianeptine suppresses asthmatic symptoms in children: a double-blind, crossover, placebo-controlled study.J Clin Pharmacol. 1998 Oct;38(10):918-25. doi: 10.1002/j.1552-4604.1998.tb04387.x. J Clin Pharmacol. 1998. PMID: 9807972 Clinical Trial.
-
Acute effects of tianeptine on circulating neurotransmitters and cardiovascular parameters.Prog Neuropsychopharmacol Biol Psychiatry. 2006 Mar;30(2):214-22. doi: 10.1016/j.pnpbp.2005.10.013. Epub 2005 Nov 21. Prog Neuropsychopharmacol Biol Psychiatry. 2006. PMID: 16303223 Clinical Trial.
-
5-HT modifiers as a potential treatment of asthma.Trends Pharmacol Sci. 2000 Jan;21(1):13-6. doi: 10.1016/s0165-6147(99)01408-x. Trends Pharmacol Sci. 2000. PMID: 10637649 Review.
-
Tianeptine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in depression and coexisting anxiety and depression.Drugs. 1995 Mar;49(3):411-39. doi: 10.2165/00003495-199549030-00007. Drugs. 1995. PMID: 7774514 Review.
Cited by
-
Allergen and ozone exacerbate serotonin-induced increases in airway smooth muscle contraction in a model of childhood asthma.Respiration. 2012;83(6):529-42. doi: 10.1159/000336835. Epub 2012 Apr 13. Respiration. 2012. PMID: 22507883 Free PMC article.
-
A Case of 'Neptune's Fix Elixir': The Dangerous Consequences of Unregulated Use of Tianeptine in Over-the-Counter Products.Cureus. 2024 Feb 28;16(2):e55120. doi: 10.7759/cureus.55120. eCollection 2024 Feb. Cureus. 2024. PMID: 38558634 Free PMC article.
-
Platelets, Not an Insignificant Player in Development of Allergic Asthma.Cells. 2021 Aug 10;10(8):2038. doi: 10.3390/cells10082038. Cells. 2021. PMID: 34440807 Free PMC article. Review.
-
Emerging Roles of Platelets in Allergic Asthma.Front Immunol. 2022 Apr 1;13:846055. doi: 10.3389/fimmu.2022.846055. eCollection 2022. Front Immunol. 2022. PMID: 35432313 Free PMC article. Review.
-
5-hydroxytryptamine modulates migration, cytokine and chemokine release and T-cell priming capacity of dendritic cells in vitro and in vivo.PLoS One. 2009 Jul 31;4(7):e6453. doi: 10.1371/journal.pone.0006453. PLoS One. 2009. PMID: 19649285 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical